Spectral Diagnostics (OTCMKTS:EDTXF) Trading Up 0.4% – What’s Next?

Posted by on Jun 19th, 2026

Shares of Spectral Diagnostics Inc. (OTCMKTS:EDTXF – Get Free Report) traded up 0.4% on Wednesday . The company traded as high as $0.9998 and last traded at $0.99. 30,900 shares traded hands during trading, an increase of 612% from the average session volume of 4,337 shares. The stock had previously closed at $0.9860.

Spectral Diagnostics Price Performance

The company has a 50-day moving average price of $1.01 and a two-hundred day moving average price of $0.99. The stock has a market capitalization of $283.14 million, a P/E ratio of -9.65 and a beta of 0.09.

Spectral Diagnostics (OTCMKTS:EDTXF – Get Free Report) last released its quarterly earnings data on Friday, May 8th. The company reported ($0.01) EPS for the quarter, meeting analysts’ consensus estimates of ($0.01). The firm had revenue of $0.64 million during the quarter, compared to the consensus estimate of $0.54 million.

Spectral Diagnostics Company Profile

(Get Free Report)

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.

Featured Articles

Receive News & Ratings for Spectral Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.